Benelux’s strong science base eyed for biotech scaling despite funding gaps

Belgium and the Netherlands have built some of Europe’s strongest life‑science ecosystems, anchored by leading research institutions and a growing pool of biotech talent.

Early‑stage capital remains scarce and investment is often fragmented across regions, creating challenges for biotech founders seeking funding.

Investors point to national biotech initiatives and broader EU support as potential catalysts that could unlock larger scale growth and encourage a coordinated national strategy.

Key hubs such as Ghent and Leuven in Belgium, along with collaborative models like the VIB, illustrate how strong scientific foundations and talent recycling may drive future expansion.